CMMB FY 2017 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$51,000

Operating Income

-$9M

Net Income

-$10M

EPS (Diluted)

$-875.98

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2M

Total Liabilities

$3M

Stockholders' Equity

-$609,000

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$51,000	-$40,638	-25.5%
Operating Income	-$9M	-$5M	-102.7%
Net Income	-$10M	-$5M	-107.2%